We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools.

Our Solo II™ High Resolution Breast PET scanner detects breast cancers as small as 1.6 mm. It’s the industry leader in sensitivity and specificity in characterizing the extent and location of previously diagnosed breast cancers. It’s ideal for enhancing surgical planning, monitoring patient response to chemotherapy and evaluating suspected recurrence.

Our Naviscan Stereo Navigator is the first FDA-cleared commercially available breast PET guided biopsy accessory.

In 2017, we added LumaGem to our portfolio of devices, furthering our commitment to earlier, more accurate detection of breast cancer.

CMR Naviscan is headquartered in Carlsbad, California, is US FDA registered and ISO 13485:2012 certified.


For over 25 years, Compañía Mexicana de Radiología (CMR) has been a developer and manufacturer of high quality diagnostic imaging equipment and healthcare IT solutions. Founded in 1973, it has an installed base of over 6000. CMR is headquartered in Querétaro, México.

For more information about CMR, please visit cmr-rx.com.


Electrónica y Medicina, S.A. (EYMSA) was founded in May 1979, to provide service to x-Ray equipment, particularly General Electric devices in Mexico. In 1982, EYMSA began its decade as the sole distributor for GE Mexico. In 1992, EYMSA made distribution agreements with several companies including Shimadzu, Diasonics, and Varian.


dence breast